Research Areas

Discover approaches that shorten the path from DNA constructs to purified, functional proteins.

By replacing conventional plasmid systems, cell-free DNA synthesis improves speed and quality in mRNA research.

After a decade of promise, AAV therapies are now confronting economic, clinical, and regulatory hurdles.

ImmunoVec will use a $40.7 million grant to advance its polymeric nanoparticle platform toward a first-in-human trial for autoimmune diseases.

Company is first to deliver ultra-long, fully verified DNA in less than 25 days, backed by the industry’s only on-time guarantee

Under the new partnership, Biodesix will lead development and regulatory efforts for Bio-Rad’s ddPLEX ESR1 assay, enabling sensitive ctDNA-based mutation testing.

A new study showed that adding a drug to inhibit the OPA1 protein could reverse resistance to a frontline treatment in patients with AML.

Enamine’s chemistry platform delivered over 2,000 novel compounds to accelerate the discovery of pre-clinical candidate ASAP-0017445.

The employee-owned chromatography company celebrates four decades of innovation, quality, and community while looking ahead to a bright future.

Learn how various 3D cell culture systems differ in design, function, and application in biomedical research.